The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease
Open accessAbstract
OBJECTIVE: To determine the frequency and correlates of impulse control disorders (ICDs) in Parkinson disease (PD). DESIGN: An unstructured screening interview for ICDs (compulsive gambling, buying, and sexual behavior) followed by a telephone-administered structured interview for screen-positive patients. SETTING: Two university-affiliated movement disorders centers. PARTICIPANTS: A convenience sample of 272 patients with idiopathic PD who were screened for psychiatric complications. MAIN OUTCOME MEASURES: Presence of compulsive gambling, buying, or sexual behavior as assessed by the Minnesota Impulsive Disorders Interview. RESULTS: Eighteen patients (6.6%) with PD met criteria for an ICD at some point during the course of PD, including 11 (4.0%) with an active ICD. Compulsive gambling and compulsive sexual behavior were equally common. In a multivariate model, treatment with a dopamine agonist (P = .01) and a history of ICD symptoms prior to PD onset (P = .02) predicted current ICD. There were no differences between the dopamine agonists in their association with ICDs (P = .21), and daily doses of dopamine agonists were higher in patients with an ICD than in dopamine agonist-treated patients without an ICD (P < .001). CONCLUSIONS: Patients with PD treated with a dopamine agonist should be made aware of the risk of developing an ICD and monitored clinically. Because dopamine agonists are increasingly being used for other indications, future research should assess the dopamine agonist-associated risk for ICDs in other populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“impulse-control disorder (ICD) development in PD patients has been associated with dopamine agonist pharmacotherapy (Weintraub et al., 2006”
From Remote delivery of psychological interventions for Parkinson's disease. (2018) · cites this paper as Weintraub et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Sheikh (1986) · doi:10.1300/j018v05n01_09 · Cited by 7,236
An algorithm (decision tree) for the management of Parkinson’s disease (2001):
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 724
Compulsive buying: descriptive characteristics and psychiatric comorbidity.
Ga, C., Faber, R., de Zwaan, M., Raymond, N. C., Sm, S., Ekern, Tb, M., Crosby, R. D., Sj, C., & Ed, E. (1994) · PubMed · Cited by 664
Giovannoni, G. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563
Flagged first, then by citations
Research works printed but not linked: 2
- [4]American Psychiatric Association. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000. Diagnostic and Statistical Manual of Mental Disorders. [Google Scholar]
- [6]Tyne HL, Medley G, Ghadiali E, Steigner MJ. Gambling in Parkinson’s disease. Movement Disorders. 2004;19(suppl 9):S195. [Google Scholar]
Cited by
Sorted by citations
Items 401–500 of 661
Chung, S. J., Asgharnejad, M., Bauer, L., Benitez, A., Boroojerdi, B., Heidbrede, T., Little, A. F. M., & Kim, H. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1336087 · Cited by 10
Rigon, L., Fogliano, C. A., Chaudhuri, К. R., Popławska-Domaszewicz, K., Falup‐Pecurariu, C., Murășan, I., Wolfschlag, M., Odin, P., & Antonini, A. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2485337 · Cited by 10
Glücksspiel im Gehirn: Neurobiologische Grundlagen pathologischen Glücksspielens
Mörsen, C. P., Heinz, A., Fauth‐Bühler, M., & Mann, K. F. (2011) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911.a000121 · Cited by 9
Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
Yang, X. Q., Glizer, D., Vo, A., Seergobin, K. N., & MacDonald, P. A. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00523 · Cited by 10
“…Weintraub et al., 2010), the percentage of patients experiencing this symptom on DAs is much higher (Driver-Dunckley et al., 2003; Pontone et al., 2006; Voon et al., 2006; Weintraub et al., 2006, 2010; Gallagher et al., 2007; Bostwick et al., 2009; Claassen et al., 2011; Garcia-Ruiz et al., 2014).”
BackgroundRisk of Pathological Gambling and Impulse Control Disorders With Dopamine Agonists
Sodhi, M., Etminan, M., Carleton, B., & Samii, A. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001122 · Cited by 9
Orrù, M., Strathman, H. J., Floris, G., Scheggi, S., Levant, B., & Bortolato, M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.005 · Cited by 9
Krysiak, R. G., Kowalcze, K. E., & Okopień, B. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.03.001 · Cited by 9
Floris, G., Scheggi, S., Pes, R., & Bortolato, M. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.01.020 · Cited by 8
Kimura, I., Revankar, G. S., Ogawa, K., Amano, K., Kajiyama, Y., & Mochizuki, H. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103307 · Cited by 9
Dopamine dysregulation syndrome
Kondo, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-4003-8 · Cited by 9
“In the case of PD, addictive use of levodopa and a high dose of dopamine agonist [28], particularly those that have potent D3 agonistic action [7, 8, 19], is thought to be one of the causes of DDS, because D3 receptors are distributed densely in the mesolimbic system of the brain [23].”
BackgroundBehavioral and Pharmacological Treatment of Compulsive Sexual Behavior/Problematic Hypersexuality
Leppink, E. W., & Grant, J. E. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0122-y · Cited by 9
Can Slot-Machine Reward Schedules Induce Gambling Addiction in Rats?
Laskowski, C. S., Dorchak, D., Ward, K., Christensen, D. R., & Euston, D. R. (2019) · Journal of Gambling Studies · doi:10.1007/s10899-019-09852-1 · Cited by 9
Izzo, V. A., Donati, M. A., Ramat, S., & Primi, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217700 · Cited by 9
Leplow, B., Renftle, D., Rutenkröger, M., Michaelis, K., Solbrig, S., Maetzler, W., Berg, D., & Liepelt‐Scarfone, I. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02588-8 · Cited by 8
Hall, A., Weightman, M., Jenkinson, N., & MacDonald, H. J. (2023) · Experimental Brain Research · doi:10.1007/s00221-023-06584-y · Cited by 8
Mishal, B., Shetty, A., & Wadia, P. M. (2023) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_37_22 · Cited by 9
Pathological gambling in Parkinson’s disease: disease related or drug related?
Calandrella, D., & Antonini, A. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.70 · Cited by 8
Chung, C., Kuo, Y.-C., Hsieh, Y.-Y., Li, T., Lin, C., Liang, W.-M., Liao, L.-N., Li, C.-I., & Lin, H.-C. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.08.011 · Cited by 8
Marín‐Lahoz, J., Martínez‐Horta, S., Sampedro, F., Pagonabarraga, J., Horta‐Barba, A., Bejr‐Kasem, H., Boti, M. A., de Bobadilla, R. F., Pascual‐Sedano, B., Pérez‐Pérez, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14235 · Cited by 8
“In PD, ICDs are much more prevalent than in the general population, and they have been consistently associated with the use of dopamine agonists [3].”
BackgroundWexler, T., & Page‐Wilson, G. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15660 · Cited by 8
“gambling, compulsive shopping, hypersexuality and binge-eating disorders have all been observed.(145,146) The data on impulse control disorders in patients with pituitary tumours treated with DAs have evolved over the last decade, beginning with case reports of impulse control disorders in treated patients with prolac…”
BackgroundPsychiatric Issues in Parkinson's Disease
Weintraub, D. A. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00013-1 · Cited by 8
Self-citationPathological gambling and hypersexuality due to dopaminergic treatment in Parkinson' disease.
Fernández, F. M., & González, T. M. (2009) · PubMed · Cited by 8
Treating Compulsive Buying Disorder
Koran, L., & Aboujaoude, E. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0024-3 · Cited by 8
“episode in bipolar disorder, or as a result of dopaminergic overstimulation from anti-Parkinsonian medications [10].”
Majláth, Z., Toldi, J., Fülöp, F., & Vécsei, L. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160212121915 · Cited by 7
Preservation of brain metabolism in recently diagnosed Parkinson’s impulse control disorders
Marín‐Lahoz, J., Sampedro, F., Horta‐Barba, A., Martínez‐Horta, S., Aracil‐Bolaños, I., Camacho, V., Bejr‐Kasem, H., Pascual‐Sedano, B., Pérez‐Pérez, J., Gironell, A., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04664-2 · Cited by 8
DiMarco, E. K., Sadibolova, R., Jiang, A., Liebenow, B., Jones, R., Haq, I. U., Siddiqui, M., Terhune, D. B., & Kishida, K. T. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105800 · Cited by 7
Walton, M. T., Cantor, J. M., Bhullar, N., & Lykins, A. D. (2017) · Archives of Sexual Behavior · doi:10.1007/s10508-017-1111-5 · Cited by 7
“…of exogenous substances (e.g., drugs ofabuse), a generalmedical condition or psychological disorder (e.g., bipolar), or various neurocognitive disorders (e.g., Parkinson’s disease) (American Psychiatric Association, 2013; Metin et al., 2013; Politis et al., 2013; Weintraub et al., 2006, 2010).”
BackgroundTinospora cordifolia attenuates antipsychotic drug induced hyperprolactinemia in Wistar rats
Tiwari, P. K., Dubey, S. K., & Sahu, P. K. (2019) · Asian Pacific Journal of Reproduction · doi:10.4103/2305-0500.259171 · Cited by 7
“However, usage of dopamine receptor agonist has a grey side as it manifests to development of mental fogginess and postural hypotension which limits their therapeutic utility which cannot be ignored or subsided[13,14].”
BackgroundRuitenberg, M. F. L., Koppelmans, V., Wu, T., Averbeck, B. B., Chou, K. L., & Seidler, R. D. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06423-6 · Cited by 7
“Impulse control disorders (ICDs) refer to a set of behavioral disturbances in which a person lacks voluntary control over impulses, drives, or temptations to engage in excessive hedonic actions (Gatto and Aldinio 2019; Weintraub et al. 2006, 2015).”
BackgroundNonmotor symptoms in Parkinson's disease: classification and management
Erro, R., Santangelo, G., Barone, P., & Vitale, C. (2015) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s44382 · Cited by 8
Impulse control disorders and dopaminergic treatments in Parkinson's disease
Villa, C., Pascual‐Sedano, B., Pagonabarraga, J., & Kulisevsky, J. (2011) · Revue Neurologique · doi:10.1016/j.neurol.2011.01.018 · Cited by 7
Carrière, N., Kreisler, A., Dujardin, K., Destée, A., & Defebvre, L. (2011) · Revue Neurologique · doi:10.1016/j.neurol.2011.07.010 · Cited by 7
Measurement properties from the Brazilian Portuguese version of the QUIP-RS
Guerra, D. F., Silva, A. E. L., Paz, T. D. S. R., Filho, L. N. S., Vasconcellos, L. F., de Britto, V. L. S., Allodi, S., Weintraub, D. A., Swarowsky, A., & Corrêa, C. L. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0108-2 · Cited by 7
“In order to obtain levodopa equivalent daily dose (LEDD), the equivalent units used in the study were: 100mg levodopa= 130mg controlledrelease levodopa= 70mg levodopa+ catechol inhibitor-O-methyl transferase (COMT inhibitor)= 1mg pergolide= 1mg pramipexole= 5mg ropinirole.(16) Considering that the QUIP-RS investigates…”
MethodSelf-citationChoi, J.-H., Lee, J., Cho, J. W., Ko, S.-B., Ahn, T., Kim, S. J., Cheon, S., Kim, J., Kim, Y. J., Ma, H., et al. (2020) · Journal of Clinical Neurology · doi:10.3988/jcn.2020.16.2.245 · Cited by 8
“250 J Clin Neurol 2020;16(2):245-253 Validation of the Korean Version of the QUIP-RS JCN”
MethodInfluentialIzzo, V. A., Donati, M. A., Torre, E., Ramat, S., & Primi, C. (2019) · Journal of Neuropsychology · doi:10.1111/jnp.12193 · Cited by 7
The safety of dopamine agonists in the treatment of Parkinson's disease
Bonuccelli, U., & Ceravolo, R. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.2.111 · Cited by 7
Epidemiology of Psychiatric Symptoms in Parkinson’s Disease
Leentjens, A. F. G. (2012) · Advances in biological psychiatry · doi:10.1159/000331522 · Cited by 7
Alteraciones de la esfera emocional y el control de los impulsos en la enfermedad de Parkinson
Fernández‐Prieto, M., Lens, M., Real, A. L., Puy, A., Silva, J. J. D., & Sobrido, M. J. (2010) · Revista de Neurología · doi:10.33588/rn.50s02.2009738 · Cited by 7
Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors
Leclercq, V., & Corvol, J. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2024.07.001 · Cited by 6
Buhmann, C. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2021.12.001 · Cited by 6
Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
Jeyadevan, A., Bakeberg, M. C., Byrnes, M. L., Kenna, J. E., McGregor, S., Ghosh, S., Horne, M. K., Stell, R., Evans, T., Mastaglia, F. L., et al. (2023) · Quality of Life Research · doi:10.1007/s11136-022-03321-w · Cited by 6
“Amongst PwP, high levels of self-reported trait impulsivity are generally observed [15, 18, 19], this is notable as it represents a significant risk factor for development of Impulse Control Disorders (ICDs) [8].”
BackgroundNeuronal and psychological underpinnings of pathological gambling
Singer, B. F., Anselme, P., Robinson, M. J. F., & Vezina, P. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00230 · Cited by 8
Is premature ejaculation an impulse control disorder?
Özdemir, O. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.03.034 · Cited by 6
“A rangeof impulse controlbehaviourshavebeen reported following theuseofdopamineagonists (DAs)and levodopa inpatientswith Parkinson’s disease [52].”
BackgroundInitial Treatment of Parkinson’s Disease: An Update
Kaplan, S., & Tarsy, D. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0236-7 · Cited by 8
Grandgenèvre, P., Warembourg, F., Carrière, N., Vaillant, A., Defebvre, L., & Vaïva, G. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2014.06.037 · Cited by 6
Guridi, J., & Aldave, G. N. J. (2011) · Neurocirugía · doi:10.1016/s1130-1473(11)70001-x · Cited by 6
Guo, H., Ye, L., Jia, L., Zhang, L., & Qi, F. (2012) · Chinese Journal of Chemical Physics · doi:10.1088/1674-0068/25/01/11-18 · Cited by 6
Gungabissoon, U., Kirichek, O., Baou, C. E., & Galwey, N. W. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4986 · Cited by 6
Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson’s Disease
Choi, J.-H., Lee, J., Jeon, B., Koh, S., Yoon, W. T., Lee, H., Kwon, O. D., Kim, J. W., Kim, J., Ma, H., et al. (2019) · Neurodegenerative Diseases · doi:10.1159/000507447 · Cited by 6
Assessment Instruments for Impulsivity and Impulse Control Disorders
Matusiewicz, A. K., Reynolds, B. A., & Lejuez, C. W. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195389715.013.0141 · Cited by 6
Modulation of Habit Formation by Levodopa in Parkinson's Disease
Marzinzik, F., Wotka, J., Wahl, M., Krugel, L. K., Kordsachia, C. C., & Klostermann, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027695 · Cited by 6
“clinical perspective, because dopaminergic replacement therapy in PD is usually associated with the evolution of impulsivecompulsive behaviour [34–43].”
Ayoub, S. M., Libster, A. M., Barnes, S. A., Dulawa, S. C., & Young, J. W. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109851 · Cited by 6
Staubo, S. C., Fuskevåg, O., Toft, M., Lie, I. H., Alvik, K. M. J., Jostad, P., Tingvoll, S. H., Lilleng, H., Rosqvist, K., Størset, E., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-024-12870-8 · Cited by 5
Wilson, L., Sheehan, J., & Thorpe, M. (2013) · PubMed · Cited by 5
Zesiewicz, T., Kesayan, T., Shaw, J., Jones, T., & Staffetti, J. F. (2015) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s37268 · Cited by 5
“However, one recent multicenter study showed that RTG led to a lower incidence of ICDs than other DAs, and can be better tolerated in patients who are prone to ICDs.(12,13) Use of DAs, including RTG, can result in patients falling asleep during activities of daily living, hallucinations, and psychosis or worsening psy…”
Motivational Sensitivities Linked to Impulsive Motor Errors in Parkinson’s Disease
Laurent, R. L., van Wouwe, N. C., Turchan, M., Tolleson, C., Phibbs, F. T., Bradley, E. B., van den Wildenberg, W. P. M., & Wylie, S. A. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000741 · Cited by 5
Williams, I. A., Obeso, I., & Jahanshahi, M. (2020) · Neuropsychology · doi:10.1037/neu0000629 · Cited by 5
“The increased incidence of Impulse Control Disorders in PD patients taking dopaminergic therapy would suggest that dopaminergic medication induces or worsens impairments in inhibitory control (Weintraub et al., 2006).”
BackgroundDefinition and Classification of Parkinsonian Drugs
Mizuno, Y. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_213 · Cited by 5
Intervening in the neuropsychiatric features of Parkinson’s disease
Weintraub, D. A., & Stern, M. B. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.699 · Cited by 5
Self-citationHow May Neuroscience Affect the Way that the Criminal Courts Deal with Addicted Offenders?
Hall, W., & Carter, A. (2013) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199925605.003.0012 · Cited by 5
The Experience of care-giving for a person with Parkinson’s Disease.
Bogard, C. L. (2010) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 5
Korczyn, A. D., Balash, Y., & Gurevich, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00323-4 · Cited by 5
Sexual dysfunction in Parkinson's disease: what about women?
Panichelli, B. S., Rosa-Campos, F., Chaves, F. S., de Oliveira, C. G., Jardim, M. R., & Spitz, M. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.125757 · Cited by 4
A neurological perspective on the enhancement debate: Lessons learned from Parkinson’s disease
Kehagia, A. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116665328 · Cited by 3
“DA agonists in particular have been implicated in the genesis of this neuropsychiatric complication (Weintraub et al., 2006), which is incidentally also seen in other conditions treated with these agents, such as restless leg syndrome (Cornelius et al.”
BackgroundTrait Impulsivity Is Independent of Mild Cognitive Impairment in a Parkinson’s Disease Cohort
Jeyadevan, A., Bakeberg, M. C., Byrnes, M. L., Kenna, J. E., Ghosh, S., Stell, R., Walters, S., Evans, T., McGregor, S., Horne, M. K., et al. (2019) · Parkinson s Disease · doi:10.1155/2019/2672075 · Cited by 4
Mena-Moreno, T., Munguía, L., Granero, R., Lucas, I., Sánchez‐Gómez, A., Cámara, A., Compta, Y., Valldeoriola, F., Fernández‐Aranda, F., Sauvaget, A., et al. (2022) · JMIR Serious Games · doi:10.2196/33858 · Cited by 7
“In patients with PD, the most frequent forms of ICD include gambling disorder (GD), which is also considered a behavioral addiction, but in any case a disorder related to impulsivity; compulsive shopping; hypersexuality; binge eating disorder, considered as an eating disorder in terms of diagnostics, but highly relate…”
BackgroundWhite matter hyperintensities associated with impulse control disorders in Parkinson’s Disease
Hernádi, G., Perlaki, G., Kovács, M. Á., Pintér, D., Orsi, G., Janszky, J., & Kovács, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-37054-8 · Cited by 3
Gopalan, P. R., Azzam, P. N., & Hudak, R. (2012) · Psychosomatics · doi:10.1016/j.psym.2012.07.001 · Cited by 4
London, D., Pourfar, M., & Mogilner, A. Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00270 · Cited by 4
“Unsurprisingly, DBS of the STN, like dopaminergic medication (Weintraub et al., 2006), may cause impulse control disorders (Hälbig et al.”
BackgroundGarcía-Rubio, M. I., Cerdeira, M. E. O., Toledo-Lozano, C. G., Alcaráz‐Estrada, S. L., Suárez‐Cuenca, J. A., Coral‐Vázquez, R. M., Mondragón‐Terán, P., Pineda-Juárez, J. A., Díaz-López, L. F., & Garcı́a, S. (2021) · Healthcare · doi:10.3390/healthcare9101263 · Cited by 4
Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?
Fründt, O., Fadhel, M., Heesen, C., Zai, S. S., Gerloff, C. P., Vettorazzi, E., Pöttgen, J., & Buhmann, C. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223420 · Cited by 4
Williams, W. A., Grant, J. E., Winstanley, C. A., & Potenza, M. N. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00029-1 · Cited by 4
Self-citationCompulsive Masturbation With Pramipexole for Antidepressant Augmentation in Major Depression
Rocha, F. L., & Hara, C. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000363 · Cited by 4
DIAGNOSTIC APPROACH TO BEHAVIORAL OR "NON-SUBSTANCE" ADDICTIONS
Şenel, G. B., & Poyraz, C. A. (2014) · Cited by 4
Impulse control disorder, lysosomal malfunction and ATP13A2 insufficiency in Parkinsonism
Liu, J.-P., Li, J.-F., Lu, Y., Wang, L.-H., & Chen, G. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12714 · Cited by 4
Tangedal, N. M., & Tysnes, O. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.108147 · Cited by 3
Carrillo, F., & Mir, P. (2012) · InTech eBooks · doi:10.5772/18648 · Cited by 3
Independent and Complementary Validation of the QUIP‐RS in Advanced Parkinson's Disease
Martínez‐Martín, P., Rodríguez‐Blázquez, C., Catalán, M. J., & The EDIS Study Group (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12603 · Cited by 3
“quently observed, especially in relation to dopamine agonist therapy.(1) The present study seeks to perform a complementary”
BackgroundCreativity in patients with Parkinson's disease
Катунина, Е. А., Shipilova, N. N., Titova, N., Maluchina, E. A., Zhuk, V. A., & Ivanova, M. Z. I. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119111128 · Cited by 3
ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE
Dagher, A. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03624.x · Cited by 3
Understanding Parkinson disease
Vernon, G. M., Carty, A. E. S., Salemno, C. M., Siskind, M. M., & Thomas, C. A. (2014) · The Nurse Practitioner · doi:10.1097/01.npr.0000453646.44157.83 · Cited by 3
The Neuropsychopharmacology of Pathological Gambling
Zakeri, K., & Potenza, M. N. (2012) · Current Psychiatry Reviews · doi:10.2174/157340012798994911 · Cited by 4
Self-citationThe Prevalence of Gambling Among University Students: With a Focus on Internet Gambling
Sammut, M., & Dissertation, A. (2010) · Cited by 3
Impulse control disorders and related behaviors
Weintraub, D. A., & Rektorová, I. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.014 · Cited by 3
Self-citationNeurotoxic Effects of Pharmaceutical Agents III: Neurological Agents
Kennedy, K. A., & Ryan, M. A. (2009) · Elsevier eBooks · doi:10.1016/b978-032305260-3.50038-1 · Cited by 3
Epidemiology and Phenomenology of Pathological Gambling
Clark, L. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195389715.013.0035 · Cited by 3
O’Sullivan, J. D. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322378 · Cited by 3
Kjær, S. W., Callesen, M. B., Larsen, L. P. S., Borghammer, P., Østergaard, K., & Damholdt, M. F. (2020) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2020.1749237 · Cited by 3
“Studies have suggested the use of DAs to be associated with impulsivity and impulse control disorders in individuals with PD (Djamshidian et al., 2014; Weintraub et al., 2006).”
BackgroundTorre, G. L., Herman, A. M., Jessop, M., Abdula, N., Crawshaw, A. A., Begley, P., Wroe, E., Saha, R. A., Duka, T., & Dizdarevic, S. (2020) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001267 · Cited by 3
Stratégies médicamenteuses antiparkinsoniennes
Vérin, M. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-71153-4.00012-3 · Cited by 3
Definition and Classification of Parkinsonian Drugs
Mizuno, Y. (2019) · Springer eBooks · doi:10.1007/978-3-319-56015-1_213-1 · Cited by 3
Anatomy and Physiology of Limbic System Dysfunction in Parkinson's Disease
Grace, A. A. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch6 · Cited by 3
Korczyn, A. D. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00028-9 · Cited by 3
Daniel, K. B., Glezer, A., Queiroz, N. L., Correa‐Silva, S. R., Trentin, M. B. F., Fujiwara, M. T., Benetti‐Pinto, C. L., Kasuki, L., Tavares, L. A. G., Rosário, P. W., et al. (2026) · Pituitary · doi:10.1007/s11102-026-01728-z · Cited by 2
Arts, K. (2014) · Tijdschrift voor Neuropsychiatrie en Gedragsneurologie · doi:10.1007/s40533-014-0003-4 · Cited by 2
Neurocognitive Process of Problem Solving and Decision Making: A Traditional Review
Seçer, E., & Kaya, D. Ö. (2022) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2021-83167 · Cited by 2
Green, M. A., Crawford, J. L., Kuhnen, C. M., Samanez-Larkin, G. R., & Seaman, K. L. (2023) · Cerebral Cortex Communications · doi:10.1093/texcom/tgad008 · Cited by 2
“that some middle-aged and older individuals with Parkinson’s Disease (PD) who are treated with dopamine agonists develop novel gambling addictions and engage in other excessively risky behaviors (Weintraub et al., 2006).”
BackgroundBidirectional modulation of reward-guided decision making by dopamine
Maile, A. A. D., Gründler, T. O. J., Fischer, A. G., Kurtenbach, H., Kaiser, L. F., Froböse, M. I., & Jocham, G. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06816-9 · Cited by 2
“Conversely, treating the dopamine deficit with the dopamine-precursor levodopa (L-DOPA, [3]) improves the motor symptoms but it can also increase risk seeking behavior and even cause impulse control disorders such as pathological gambling [4-6].”
Tichelaar, J. G., Hezemans, F. H., Bloem, B. R., Helmich, R. C. G., & Cools, R. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.027 · Cited by 2
“In addition, younger age (8,26 – 28) [at disease onset (24,27)]; male sex (8,18,20,27); a (family) history of addictive behavior (23 – 25); more severe nonmotor symptoms (21,22,27), especially depression (18,20,22,29); more severe motor phenotype (21,25); dyskine-sias (8); and certain genetic…”
Therapy of the Motor Features of Parkinson's Disease
Fox, S. H., & Lang, A. E. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00015-5 · Cited by 2
Metadata
- Authors
- Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2006-07-01
- Volume
- 63
- Issue
- 7
- Pages
- 969
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC1761054
- OpenAlex
- W2035890213
- Cited by
- 662
- References
- 17
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 12 · 2023: 16 · 2022: 18 · 2021: 18 · 2020: 36 · 2019: 38 · 2018: 23 · 2017: 32 · 2016: 40 · 2015: 26 · 2014: 40 · 2013: 45 · 2012: 40
- FWCI
- 30.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K23MH067894)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- Parkinson's disease, impulse control disorders, dopamine agonists, gambling addiction, compulsive buying, compulsive sexual behavior, psychiatric complications, adverse drug reactions, risk factors, dose-response relationship
- MeSH terms
- Pramipexole, Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Gambling, Humans, Disruptive, Impulse Control, and Conduct Disorders, Indoles, Male, Middle Aged, Parkinson Disease, Pergolide, Risk Factors, Sexual Behavior, Sexual Dysfunction, Physiological, Thiazoles, Logistic Models, Dopamine Agonists, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
